The Washington Tax & Public Policy Group O/b/o Alliance for Biopharma

lobbying firm

Based in DC

🤖

AI Overview

With $155K in lobbying spend across 14 quarterly filings, The Washington Tax & Public Policy Group O/b/o Alliance for Biopharma is an active lobbying client. Their lobbying covers 1 issue area. Active from 2020 to 2023.

$155K

Total Spend

Years Active

Firms Hired

Lobbyists Deployed

Issues Lobbied

Spending Trend

View as table

Year	Lobbying Spend
2020	$35K
2021	$60K
2022	$40K
2023	$20K

Issues Lobbied

Taxation

Lobbying Firms

Domer Consulting, LLC

Lobbyists

Regina Mahony

Government Agencies Targeted

These are the government entities that The Washington Tax & Public Policy Group O/b/o Alliance for Biopharma disclosed contacting in their lobbying filings.

HOUSE OF REPRESENTATIVESSENATE

View all agency pressure data →

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Taxation

Issues related to the taxation of the biopharmaceutical industry including international taxation

Issues related to corporate and international tax, including issues related to the taxation of manufacturing income and capital investment in the United States and Puerto Rico and issues related to th

Issues related to corporate and international tax, including issues related to rates, tax code section 951A, issues related to the taxation of manufacturing income and capital investment in the United

Issues related to corporate and international tax, including issues related to corporate tax rates, issues related to the taxation of foreign income, tax code sections 951A and 954(c)(6), issues relat

Issues related to corporate and international taxation, including issues related to corporate tax rates, issues related to the taxation of foreign income, including tax code sections 951A, 250 and 59A